CT scans reveal body composition changes preceding pancreatic cancer diagnosis - News-Medical
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
People who develop pancreatic cancer experience measurable changes in body composition years before diagnosis that differ from those seen in similar individuals without cancer, according to a Mayo Clinic study led by former Mayo Clinic research fellow, Aleksander Bogdanski and published in Pancreatology.
Pancreatic cancer remains one of the deadliest cancers, largely because most patients are diagnosed after the disease has already spread. Current surveillance programs focus primarily on people with inherited genetic risk or strong family histories, yet most pancreatic cancers occur outside those high-risk groups.
This article is an excerpt. To read the full content, visit the original source. News-Medical
Related articles
"Undruggable" No More: Takeaways from MassBio's 2026 Women's Health Symposium on Pancreatic Cancer - Massachusetts Biotechnology Council
“Undruggable.” For decades, that’s what researchers called RAS, the mutation behind about 90 percent of pancreatic cancers. Dr. Brian Wolpin of Dana-Farber Cancer Institute has a different answer: not yet. He shared it yesterday at the MassBioHub, where we hosted our fourth annual Women’s Health Symposium with the Massachusetts Caucus of Women Legislators. This year’s focus was pancreatic cancer, which is personal for this community. The Caucus lost two members to the disease last year, Rep. Ann-Margaret Ferrante and Rep. Carol Doherty.
First-in-human study attacks pancreatic cancer with laser light - UCI Health
There are a many UCI Health studies underway to help get pancreatic cancer patients to surgery and ultimately cancer-free, says Dr. Nadine Abi-Jaoudeh, who leads a novel clinical trial for the disease. "We are advocating for better options and trying to get the word out to patients. " The UCI Health Chao Family Comprehensive Cancer Center is conducting a first-in-human, phase 1 clinical trial using laser light to target localized but inoperable pancreatic tumors.
The Achilles' heel of pancreatic cancer could pave the way for new treatments - McGill University Health Centre
Interaction of Bunyamwera virus non-structural protein NSm with cellular BNIP1 is required for efficient viral gene expression and replication - Nature
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply. AbstractBunyamwera virus (BUNV) is the prototypical member of the Peribunyaviridae family of arthropod-borne viruses and possesses a genome comprising three segments of negative-sense RNA, named small, medium and large. The medium segment encodes a polyprotein that is processed to form Gn and Gc spikes and a non-structural protein, NSm. The role of NSm during replication in mammalian cells is poorly characterized, although it associates with a Golgi-derived structure called the virus factory (VF), the site of BUNV genome replication and virion assembly. To further define NSm function, we generated an epitope-tagged BUNV and used co-immunoprecipitation and quantitative proteomics to identify host interacting partners.
0 comments
No comments yet. Be the first to share your thoughts!